Cabot Corporation

NYSE:CBT Rapport sur les actions

Capitalisation boursière : US$4.5b

Cabot Gestion

Gestion contrôle des critères 3/4

Le PDG Cabot est Sean Keohane, nommé en Mar2016, a un mandat de 10.42 ans. La rémunération annuelle totale est $ 9.31M, composée du salaire de 11.8% et des bonus 88.2%, y compris les actions et options de la société. détient directement 0.59% des actions de la société, d'une valeur de $ 26.35M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 7.7 ans et 7.3 ans.

Informations clés

Sean Keohane

Directeur général

US$9.3m

Rémunération totale

Pourcentage du salaire du PDG11.82%
Durée du mandat du directeur général10.4yrs
Propriété du PDG0.6%
Durée moyenne d'occupation des postes de direction7.7yrs
Durée moyenne du mandat des membres du conseil d'administration7.3yrs

Mises à jour récentes de la gestion

Recent updates

Seeking Alpha Aug 04

Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade)

Summary Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT’s disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures. Future growth hinges on recovery in reinforcement materials and continued strength in performance chemicals, but macro risks constrain further upside. Read the full article on Seeking Alpha
Nouveau récit Aug 02

Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential

Catalysts About Cabot Cabot Corporation produces specialty chemicals and materials including reinforcement materials, performance chemicals and battery materials that serve a range of industrial and energy storage applications. What are the underlying business or industry changes driving this perspective?
Mise à jour du récit Jun 26

CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook

Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
Nouveau récit Jun 23

Battery And Data Center Demand Will Drive Long-Term Upside Potential

Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?
Article d’analyse Jun 21

Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating

Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...
Nouveau récit Jun 09

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?
Article d’analyse Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Article d’analyse Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Article d’analyse Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Article d’analyse Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Article d’analyse Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Article d’analyse Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Article d’analyse Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Article d’analyse Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Article d’analyse Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Article d’analyse Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Article d’analyse Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
Article d’analyse Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Article d’analyse Sep 25

Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Analyse de la rémunération des PDG

Comment la rémunération de Sean Keohane a-t-elle évolué par rapport aux bénéfices de Cabot?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2026n/an/a

US$187m

Mar 31 2026n/an/a

US$281m

Dec 31 2025n/an/a

US$306m

Sep 30 2025US$9mUS$1m

US$326m

Jun 30 2025n/an/a

US$418m

Mar 31 2025n/an/a

US$426m

Dec 31 2024n/an/a

US$417m

Sep 30 2024US$10mUS$1m

US$374m

Jun 30 2024n/an/a

US$470m

Mar 31 2024n/an/a

US$443m

Dec 31 2023n/an/a

US$433m

Sep 30 2023US$8mUS$1m

US$437m

Jun 30 2023n/an/a

US$300m

Mar 31 2023n/an/a

US$315m

Dec 31 2022n/an/a

US$348m

Sep 30 2022US$8mUS$1m

US$206m

Jun 30 2022n/an/a

US$142m

Mar 31 2022n/an/a

US$130m

Dec 31 2021n/an/a

US$98m

Sep 30 2021US$8mUS$1m

US$247m

Jun 30 2021n/an/a

-US$54m

Mar 31 2021n/an/a

-US$144m

Dec 31 2020n/an/a

-US$219m

Sep 30 2020US$6mUS$750k

-US$238m

Jun 30 2020n/an/a

US$65m

Mar 31 2020n/an/a

US$103m

Dec 31 2019n/an/a

US$127m

Sep 30 2019US$7mUS$988k

US$155m

Rémunération vs marché: La rémunération totale de Sean ($USD 9.31M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 6.99M ).

Rémunération et revenus: La rémunération de Sean a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Sean Keohane (59 yo)

10.4yrs
Titularisation
US$9,307,883
Compensation

Mr. Sean D. Keohane serves as Independent Director of The Chemours Company since May 3, 2018. He has been the Chief Executive Officer and President of Cabot Corporation since March 11, 2016. He was a membe...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Sean Keohane
President10.4yrsUS$9.31m0.59%
$ 26.4m
Erica McLaughlin
Executive VP8.3yrsUS$2.78m0.097%
$ 4.3m
Karen Kalita
Senior VP & General Counsel7.2yrsUS$1.98m0.059%
$ 2.7m
Jeff Zhu
Executive VP14.3yrsUS$3.52m0.13%
$ 5.7m
Lisa Dumont
VP, Controller & Chief Accounting Officer6.6yrspas de données0.026%
$ 1.2m
Patricia Hubbard
Senior VP & CTO8.5yrspas de donnéespas de données
Robert Rist
Vice President of Investor Relations & Corporate Planningless than a yearpas de donnéespas de données
Vanessa Craigie
Corporate Communications Directorno datapas de donnéespas de données
Arthur Wood
Senior VP9.3yrspas de donnéespas de données
Aaron Johnson
Senior VP of Global Business Services and Global Engineering & Inkjetno datapas de donnéespas de données
Jaume Campana
SVP & President of EMEA Region and EMEA Regional Business Dir of Reinforcement Materials Segment2.9yrspas de donnéespas de données
Jennifer Chittick
Senior VP of Safety2.6yrspas de donnéespas de données
7.7yrs
Durée moyenne de l'emploi
54.5yo
Âge moyen

Gestion expérimentée: L'équipe dirigeante de CBT est chevronnée et expérimentée (7.7 années d'ancienneté moyenne).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Sean Keohane
President10.4yrsUS$9.31m0.59%
$ 26.4m
Raffiq Nathoo
Independent Director4.3yrsUS$250.11k0.018%
$ 806.1k
Douglas Del Grosso
Independent Director6.3yrsUS$250.25k0.011%
$ 516.4k
Cynthia Arnold
Independent Director8.6yrsUS$250.12k0.027%
$ 1.2m
Frank Wilson
Independent Director7.9yrsUS$270.43k0.036%
$ 1.6m
Thierry F. Vanlancker
Independent Director2.1yrsUS$250.05k0.0095%
$ 426.2k
Christine Yan
Independent Director7.3yrsUS$261.14k0.033%
$ 1.5m
Michael Morrow
Independent Non-Executive Chair8.9yrsUS$385.52k0.0039%
$ 173.8k
Michelle Williams
Independent Director2.9yrsUS$250.07k0.013%
$ 589.2k
7.3yrs
Durée moyenne de l'emploi
64yo
Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de CBT sont considérés comme expérimentés (ancienneté moyenne 7.3 ans).


Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/08/12 19:04
Cours de l'action en fin de journée2026/08/12 00:00
Les revenus2026/06/30
Revenus annuels2025/09/30

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Cabot Corporation est couverte par 11 analystes. 6 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank